Two Sigma Advisers’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,268
| Closed | -$48K | – | 2938 |
|
|
2022
Q1 | $48K | Sell |
1,268
-737
| -37% | -$27.9K | ﹤0.01% | 2595 |
|
|
2021
Q4 | $113K | Sell |
2,005
-6,936
| -78% | -$391K | ﹤0.01% | 2395 |
|
|
2021
Q3 | $646K | Sell |
8,941
-1,269
| -12% | -$91.7K | ﹤0.01% | 1821 |
|
|
2021
Q2 | $978K | Buy |
10,210
+6,490
| +174% | +$622K | ﹤0.01% | 1652 |
|
|
2021
Q1 | $550K | Buy |
+3,720
| New | +$550K | ﹤0.01% | 1979 |
|
|
2020
Q3 | – | Sell |
-1,227
| Closed | -$216K | – | 2680 |
|
|
2020
Q2 | $216K | Buy |
+1,227
| New | +$216K | ﹤0.01% | 2227 |
|